Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00856397
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
|---|---|---|---|---|---|
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
MSQ | 4-[3-METHYLSULFANYLANILINO]-6,7- DIMETHOXYQUINAZOLINE | A | 1DI9 | 0.72 |  |
AK5 | 3-({3-[(6-amino-5-bromopyrimidin- 4-yl)sulfanyl]propanoyl}amino)- 4-methoxy-N-phenylbenzamide | A | 3DJ5 | 0.7 | |
RAR | 5-(3,4-dimethoxy-5-{(1E)-3-oxo- 3-[(1S)-1-propylphthalazin-2(1H)- yl]prop-1-en-1-yl}benzyl)pyrimidine- 2,4-diamine | A,B,C,D,E,F, G,H | 3FL8 | 0.71 | |
993 | 3-CHLORO-4-(2-METHYLAMINO-IMIDAZOL- 1-YLMETHYL)-THIOPHENE-2-CARBOXYLIC ACID [4- CHLORO-2-(5-CHLORO-PYRIDIN-2-YLCARBAMOYL)- 6-METHOXY-PHENYL]-AMIDE | B | 2P3T | 0.76 | |
TUI | 2-(4-(2-((3-(5-(PYRIDIN-2-YLTHIO)THIAZOL- 2-YL)UREIDO)METHYL)-1H-IMIDAZOL- 4-YL)PHENOXY)ACETIC ACID | A,B | 2Z6J | 0.72 | |
XLD | 3-CHLORO-N-[4-CHLORO-2-[[(5-CHLORO- 2-PYRIDINYL)AMINO]CARBONYL]-6-METHOXYPHENYL]- 4-[[(4,5-DIHYDRO-2-OXAZOLYL)METHYLAMINO]METHYL]- 2-THIOPHENECARBOXAMIDE | A | 1MQ6 | 0.72 | |
KS4 | 1-cyclobutyl-3-(3,4-dimethoxyphenyl)- 1H-pyrazolo[3,4-d]pyrimidin-4-amine | A,B | 3EN5 | 0.72 | |
SU9 | (3Z)-3-(1H-IMIDAZOL-5-YLMETHYLENE)- 5-METHOXY-1H-INDOL-2(3H)-ONE | A | 1PF8 | 0.71 | |
BRL | 2,4-THIAZOLIDIINEDIONE, 5-[[4-[2- (METHYL-2-PYRIDINYLAMINO)ETHOXY]PHENYL]METHYL]- (9CL) | A,D,U,X | 1FM6 | 0.72 | |
| BRL | 2,4-THIAZOLIDIINEDIONE, 5-[[4-[2- (METHYL-2-PYRIDINYLAMINO)ETHOXY]PHENYL]METHYL]- (9CL) | A,B | 2PRG | 0.72 | |
| BRL | 2,4-THIAZOLIDIINEDIONE, 5-[[4-[2- (METHYL-2-PYRIDINYLAMINO)ETHOXY]PHENYL]METHYL]- (9CL) | A | 1ZGY | 0.72 | |
| BRL | 2,4-THIAZOLIDIINEDIONE, 5-[[4-[2- (METHYL-2-PYRIDINYLAMINO)ETHOXY]PHENYL]METHYL]- (9CL) | A,B | 3CS8 | 0.72 | |
| BRL | 2,4-THIAZOLIDIINEDIONE, 5-[[4-[2- (METHYL-2-PYRIDINYLAMINO)ETHOXY]PHENYL]METHYL]- (9CL) | A,D | 3DZY | 0.72 | |
T2A | 5-methyl-7-phenyl-N-(3,4,5-trimethoxyphenyl)imidazo[5,1- f][1,2,4]triazin-2-amine | A,C | 3EOC | 0.71 | |
663 | 3-CHLORO-N-(4-CHLORO-2-{[(5-CHLOROPYRIDIN- 2-YL)AMINO]CARBONYL}-6-METHOXYPHENYL)- 4-[(1-METHYL-1H-IMIDAZOL-2-YL)METHYL]THIOPHENE- 2-CARBOXAMIDE | B | 2P3U | 0.77 | |
1PM | methyl (3S)-3-{2-[(1,3-benzodioxol- 5-ylmethyl)amino]-2-oxoethyl}-4- [2-(1H-imidazol-1-yl)pyrimidin- 4-yl]piperazine-1-carboxylate | A | 1DD7 | 0.74 | |
BLZ | 5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL- 1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}- 2-THIOPHENECARBOXAMIDE | A,C | 2I40 | 0.71 | |
PFE | {4-[3-(6,7-DIETHOXY-QUINAZOLIN- 4-YLAMINO)-PHENYL]-THIAZOL-2-YL}- METHANOL | A,F | 1KZ8 | 0.71 | |
090 | N-(2,3-DIHYDRO-7,8-DIMETHOXYIMIDAZO[1,2- C] QUINAZOLIN-5-YL)NICOTINAMIDE | A | 2CHX | 0.7 | |
228 | N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]- 1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN- 4-YL]-D-PROLINAMIDE | A | 2ORO | 0.74 | |
L2G | N-(4-{1-[4-(4-ACETYLPIPERAZIN-1- YL)-TRANS-CYCLOHEXYL]-4-AMINO-1H- PYRAZOLO[3,4-D]PYRIMIDIN-3-YL}- 2-METHOXYPHENYL)-1-METHYL-1H-INDOLE- 2-CARBOXAMIDE | A,B | 2C0O | 0.7 | |
R86 | 2-{(2R)-4-[2-(1H-IMIDAZOL-1-YL)- 6-METHYLPYRIMIDIN-4-YL]-1-ISOBUTYRYLPIPERAZIN- 2-YL}-N-[2-(4-METHOXYPHENYL)ETHYL]ACETAMIDE | A | 2ORP | 0.71 | |
GS7 | 2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)- 7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide | A | 3ELJ | 0.72 | |
L1G | N-(4-{4-AMINO-1-[4-(4-METHYLPIPERAZIN- 1-YL)-TRANS-CYCLOHEXYL]-1H-PYRAZOLO[3,4- D]PYRIMIDIN-3-YL}-2-METHOXYPHENYL)- 1-METHYL-1H-INDOLE-2-CARBOXAMIDE | A,B | 2C0I | 0.7 | |
AK6 | 4-methoxy-N-phenyl-3-({3-[(1H-pyrrolo[2,3- b]pyridin-5-ylmethyl)sulfanyl]propanoyl}amino)benzamide | A | 3DJ6 | 0.74 | |